Associations between readmission and patient-reported measures in acute psychiatric inpatients: a study protocol for a multicenter prospective longitudinal study (the ePOP-J study).

Sosei Yamaguchi, Yasutaka Ojio, Junko Koike, Asami Matsunaga, Makoto Ogawa, Hisateru Tachimori, Akiko Kikuchi, Hiroshi Kimura, Ataru Inagaki, Hiroyuki Watanabe, Yoshiki Kishi, Koji Yoshida, Takaaki Hirooka, Satoru Oishi, Yasuhiro Matsuda, Chiyo Fujii
Author Information
  1. Sosei Yamaguchi: 1Department of Community Mental Health & Law, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, 187-8553 Japan. ORCID
  2. Yasutaka Ojio: 1Department of Community Mental Health & Law, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, 187-8553 Japan.
  3. Junko Koike: 1Department of Community Mental Health & Law, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, 187-8553 Japan.
  4. Asami Matsunaga: 1Department of Community Mental Health & Law, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, 187-8553 Japan.
  5. Makoto Ogawa: 1Department of Community Mental Health & Law, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, 187-8553 Japan.
  6. Hisateru Tachimori: 2Translational Medical Center, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, 187-8553 Japan.
  7. Akiko Kikuchi: 1Department of Community Mental Health & Law, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, 187-8553 Japan.
  8. Hiroshi Kimura: 4Department of Psychiatry, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670 Japan.
  9. Ataru Inagaki: 6College of Education, Psychology and Human Studies, Aoyama Gakuin University, 4-4-25 Shibuya, Shibuya-ku, Tokyo, 150-8366 Japan.
  10. Hiroyuki Watanabe: Department of Psychiatry, Gakuji-kai, Kimura Hospital, 6-19 Higashi-honcho, Chuo-ku, Chiba, 260-8670 Japan.
  11. Yoshiki Kishi: 8Department of Psychiatry, Okayama Psychiatric Medical Center, 3-16 Shikata-Honmachi, Kita-ku, Okayama, Japan.
  12. Koji Yoshida: 9Department of Human Care and Support, Toyo University, 48-1 Oka, Asaka, 351-8510 Japan.
  13. Takaaki Hirooka: 10Department of Psychiatry, Kitasato University School of Medicine, 1-15-1 Kitazato, Minami, Sagamihara, 252-0374 Japan.
  14. Satoru Oishi: 10Department of Psychiatry, Kitasato University School of Medicine, 1-15-1 Kitazato, Minami, Sagamihara, 252-0374 Japan.
  15. Yasuhiro Matsuda: 11Department of Psychiatry, Nara Medical University School of Medicine, 840 Shijo, Kashihara, 634-8521 Japan.
  16. Chiyo Fujii: 1Department of Community Mental Health & Law, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, 187-8553 Japan.

Abstract

BACKGROUND: Several previous observational studies have reported the risk factors associated with readmission in people with mental illness. While patient-reported experiences and outcomes have become increasingly important in healthcare, only a few studies have examined these parameters in terms of their direct association with readmission in an acute psychiatric setting. This project will investigate multiple factors associated with readmission and community living in acute psychiatric patients in Japan. This study will primarily investigate whether patient-reported experiences at discharge, particularly quality of life (QoL), are associated with future readmission and whether readmission after the index hospitalization is associated with changes in patient-reported outcomes during the study period. Here, we describe the rationale and methods of this study.
METHODS: This multicenter prospective cohort study is being conducted in 21 participating Japanese hospitals, with a target sample of approximately 600 participants admitted to the acute psychiatric ward. The study has four planned assessment points: time of index admission (T1), time of discharge (from the index admission) (T2), 6 months after discharge from the index admission (T3), and 12 months after discharge from the index admission (T4). Participants will complete self-reported measures including a QoL scale, a subjective disability scale, and an empowerment- and self-agency-related scale at each assessment point; additionally, service satisfaction, subjective view of need for services, and subjective relationships with family members will be assessed at T2 and T3. We will assess the participants' hospitalization during the study period and evaluate several potential individual- and service-level factors associated with readmission and patient-reported experiences and outcomes. Multivariate analyses will be conducted to identify potential associations between readmission and patient-reported experiences and outcomes.
DISCUSSION: The present study may produce evidence on how patient-reported experiences at discharge influence readmission and on the influence of readmission on the course of patient-reported outcomes from admission to community living after discharge. The study may contribute to improving care for both patients' subjective views of their own health conditions and their community lives in an acute psychiatric setting. University Hospital Medical Information Network-Clinical Trials Registry (UMIN-CTR) UMIN000034220. Registered on September 20, 2018.

Keywords

References

  1. Psychol Med. 2000 Jan;30(1):225-30 [PMID: 10722193]
  2. BMJ. 1992 Oct 24;305(6860):996-8 [PMID: 1458148]
  3. Acta Psychiatr Scand Suppl. 2004;(420):47-54 [PMID: 15128387]
  4. Schizophr Bull. 2007 Sep;33(5):1225-37 [PMID: 17204532]
  5. BMJ. 2007 Oct 20;335(7624):806-8 [PMID: 17947786]
  6. Int Clin Psychopharmacol. 2008 Mar;23(2):70-83 [PMID: 18301121]
  7. Schizophr Res. 2008 Apr;101(1-3):176-84 [PMID: 18302982]
  8. Br J Psychiatry. 2009 Jan;194(1):49-54 [PMID: 19118325]
  9. Br J Psychiatry. 2010 Nov;197(5):348-9 [PMID: 21037210]
  10. Health Soc Care Community. 2011 Mar;19(2):113-25 [PMID: 21143545]
  11. Qual Life Res. 2011 Dec;20(10):1727-36 [PMID: 21479777]
  12. Psychiatr Serv. 2011 May;62(5):465-70 [PMID: 21532070]
  13. Value Health. 2012 Jul-Aug;15(5):708-15 [PMID: 22867780]
  14. Br J Psychiatry. 2012 Oct;201(4):262-7 [PMID: 23028084]
  15. Br J Psychiatry. 2013 Mar;202(3):187-94 [PMID: 23457182]
  16. Trials. 2013 Oct 17;14:337 [PMID: 24135027]
  17. Br J Cancer. 2014 Feb 4;110(3):551-5 [PMID: 24495873]
  18. World Psychiatry. 2014 Feb;13(1):12-20 [PMID: 24497237]
  19. Curr Med Res Opin. 2014 Aug;30(8):1643-55 [PMID: 24730586]
  20. Health Technol Assess. 2014 May;18(34):vii-viii, xiii-xxv, 1-188 [PMID: 24857402]
  21. World Psychiatry. 2014 Jun;13(2):118-24 [PMID: 24890055]
  22. Eur Arch Psychiatry Clin Neurosci. 2015 Apr;265(3):209-17 [PMID: 25361537]
  23. J Psychiatr Res. 2015 Feb;61:205-13 [PMID: 25537450]
  24. J Clin Psychiatry. 2015 May;76(5):e632-8 [PMID: 26035197]
  25. Front Psychiatry. 2015 Nov 18;6:161 [PMID: 26635637]
  26. World Psychiatry. 2016 Feb;15(1):13-20 [PMID: 26833597]
  27. Psychiatry Res. 2016 Jun 30;240:398-405 [PMID: 27138837]
  28. Br J Psychiatry. 2016 May;208(5):421-8 [PMID: 27143007]
  29. Cochrane Database Syst Rev. 2016 Jul 13;7:CD011119 [PMID: 27409972]
  30. J Psychiatr Ment Health Nurs. 2016 Nov;23(9-10):576-584 [PMID: 27624838]
  31. Psychol Med. 2017 Jan;47(1):53-65 [PMID: 27654902]
  32. World Psychiatry. 2016 Oct;15(3):276-286 [PMID: 27717265]
  33. BMC Psychiatry. 2016 Nov 7;16(1):376 [PMID: 27821155]
  34. BMC Psychiatry. 2016 Dec 16;16(1):449 [PMID: 27986079]
  35. BMC Psychiatry. 2017 Jan 3;17(1):2 [PMID: 28049441]
  36. Aust N Z J Psychiatry. 2017 Apr;51(4):338-354 [PMID: 28118728]
  37. Lancet Psychiatry. 2017 Apr;4(4):268-270 [PMID: 28347425]
  38. Schizophr Res. 2018 Feb;192:119-123 [PMID: 28499767]
  39. BMC Psychiatry. 2017 Jun 24;17(1):227 [PMID: 28646857]
  40. Schizophr Bull. 2018 Apr 6;44(3):631-642 [PMID: 29036720]
  41. PLoS One. 2018 Feb 27;13(2):e0192929 [PMID: 29485988]
  42. CNS Neurosci Ther. 2018 Jul;24(7):633-640 [PMID: 29575682]
  43. Neuropsychiatr Dis Treat. 2018 Mar 28;14:893-902 [PMID: 29636614]
  44. J Epidemiol. 2018 Sep 15;:null [PMID: 30224579]
  45. Psychiatry Res. 2018 Dec;270:490-495 [PMID: 30326432]
  46. Arch Gen Psychiatry. 1972 Dec;27(6):739-46 [PMID: 4637891]
  47. Arch Gen Psychiatry. 1974 Jul;31(1):37-42 [PMID: 4835985]
  48. Arch Gen Psychiatry. 1980 Apr;37(4):392-7 [PMID: 7362425]
  49. Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:89-95 [PMID: 8923116]
  50. J Nerv Ment Dis. 1998 Jul;186(7):385-92 [PMID: 9680038]

Word Cloud

Created with Highcharts 10.0.0studyreadmissionpatient-reportedwilldischargeassociatedexperiencesoutcomesacutepsychiatricindexadmissionsubjectivefactorscommunityscalestudiessettinginvestigatelivingwhetherQoLhospitalizationperiodmulticenterprospectiveconductedassessmenttimeT2T3measurespotentialmayinfluencePatient-reportedBACKGROUND:SeveralpreviousobservationalreportedriskpeoplementalillnessbecomeincreasinglyimportanthealthcareexaminedparameterstermsdirectassociationprojectmultiplepatientsJapanprimarilyparticularlyqualitylifefuturechangesdescriberationalemethodsMETHODS:cohort21participatingJapanesehospitalstargetsampleapproximately600participantsadmittedwardfourplannedpoints:T16 months12 monthsT4Participantscompleteself-reportedincludingdisabilityempowerment-self-agency-relatedpointadditionallyservicesatisfactionviewneedservicesrelationshipsfamilymembersassessedassessparticipants'evaluateseveralindividual-service-levelMultivariateanalysesidentifyassociationsDISCUSSION:presentproduceevidencecoursecontributeimprovingcarepatients'viewshealthconditionslivesUniversityHospitalMedicalInformationNetwork-ClinicalTrialsRegistryUMIN-CTRUMIN000034220RegisteredSeptember202018Associationsinpatients:protocollongitudinalePOP-JLongitudinalexperienceoutcomePsychiatrichospitalReadmission

Similar Articles

Cited By